Document Detail

Rearrangement from the heteroantiaromatic borole to the heteroaromatic azaborine motif.
MedLine Citation:
PMID:  22465974     Owner:  NLM     Status:  Publisher    
Treatment of 9-chloro-9-borafluorene with N,O-bis(trimethylsilyl)hydroxylamine results in 10-trimethylsilyloxy-9-aza-10-boraphenanthrene . NMR spectroscopy shows that the expected antiaromatic 9-(trimethylsilyloxyamino)-9-borafluorene rearranges to the formally aromatic phenanthrene at room temperature.
Sunanda Biswas; Cäcilia Maichle-Mössmer; Holger F Bettinger
Related Documents :
19781734 - Influence of operating parameters on the arsenic removal by nanofiltration.
18601274 - A novel membrane bioreactor for detoxifying industrial wastewater: ii. biodegradation o...
16278004 - Effect of heat recovery from raw wastewater on nitrification and nitrogen removal in ac...
5441254 - Use of a rapid ultrafiltration technique in the determination of plasma glycerol.
23776584 - Behavioural responses to thermal conditions affect seasonal mass change in a heat-sensi...
9241424 - Single-particle tracking: applications to membrane dynamics.
Publication Detail:
Type:  JOURNAL ARTICLE     Date:  2012-3-30
Journal Detail:
Title:  Chemical communications (Cambridge, England)     Volume:  -     ISSN:  1364-548X     ISO Abbreviation:  -     Publication Date:  2012 Mar 
Date Detail:
Created Date:  2012-4-2     Completed Date:  -     Revised Date:  -    
Medline Journal Info:
Nlm Unique ID:  9610838     Medline TA:  Chem Commun (Camb)     Country:  -    
Other Details:
Languages:  ENG     Pagination:  -     Citation Subset:  -    
Institut für Organische Chemie, Universität Tübingen, Auf der Morgenstelle 18, 72076 Tübingen, Germany.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine

Previous Document:  Unusually aggressive type 1 gastric carcinoid: a case report with a review of the literature.
Next Document:  Chronic GVHD is associated with inferior relapse risk irrespective of stem cell source among patient...